Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone.

B16 murine melanoma cells selected in vivo for enhanced liver metastatic ability (B16-LS9) show on the one hand an increased expression and constitutive activation of the proto-oncogene c-met (the receptor for hepatocyte growth factor/scatter factor), and on the other hand a more differentiated phenotype, when compared to the parental cell line, B16-F1. Following this observation, we have tried to establish whether there is a direct relationship between differentiation and c-met expression in B16 melanoma cells. Treatment of these cells with differentiating agents indicated that c-met expression was strongly induced by melanocyte stimulating hormone, while retinoic acid had almost no influence. c-met induction was triggered by engagement of the melanocortin receptor, cAMP elevation and PKA/PKC(&agr;) activation, as respectively shown by the effects of ACTH, cAMP elevating agents and specific PK inhibitors. Regulation of c-met expression via the melanocortin receptor and cAMP raises the intriguing possibility that autocrine and/or paracrine mechanisms acting in vivo on this circuit might influence (through c-met expression and activation) the metastatic behavior of these tumor cells, which we have shown to be dependent on their c-met expression.

[1]  K. Rogers,et al.  Regulation of Cl-transport in T 84 cell clones expressing a mutant regulatory subunit of cAMP-dependent protein kinase ( ion channel / cystic fibrosis / cell transfection / expression vector ) , 2004 .

[2]  M. Burger,et al.  Hepatocyte growth factor/scatter factor and hepatocytes are potent downregulators of tyrosinase expression in B16 melanoma cells , 1998, Journal of cellular biochemistry.

[3]  Shuo Lin,et al.  Influence of Hepatocyte Growth Factor/Scatter Factor on the Metastatic Phenotype of B16 Melanoma Cells , 1998, Tumor Biology.

[4]  K. Bille,et al.  In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter , 1998, Oncogene.

[5]  D. Cook,et al.  Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. , 1997, Pigment cell research.

[6]  W. Wilkison,et al.  Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. , 1997, Journal of receptor and signal transduction research.

[7]  Shigeo Ohno,et al.  Protein Kinase C δ Activates the MEK-ERK Pathway in a Manner Independent of Ras and Dependent on Raf* , 1996, The Journal of Biological Chemistry.

[8]  J. Novotný,et al.  Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C , 1996, Journal of cellular physiology.

[9]  J. B. Tatro.  Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. , 1996, Neuroimmunomodulation.

[10]  M. Burger,et al.  Constitutive Activation of c-Met in Liver Metastatic B16 Melanoma Cells Depends on Both Substrate Adhesion and Cell Density and Is Regulated by a Cytosolic Tyrosine Phosphatase Activity* , 1996, The Journal of Biological Chemistry.

[11]  M. Michalak,et al.  Inhibition of Retinoic Acid Receptor Function and Retinoic Acid-regulated Gene Expression in Mouse Melanoma Cells by Calreticulin , 1996, The Journal of Biological Chemistry.

[12]  G. V. Vande Woude,et al.  Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network , 1996, Molecular and cellular biology.

[13]  R. Niles,et al.  Retinoic acid specifically increases nuclear PKC alpha and stimulates AP-1 transcriptional activity in B16 mouse melanoma cells. , 1995, Experimental cell research.

[14]  M. Burger,et al.  Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization. , 1995, Oncogene.

[15]  Y. Nishizuka.  Protein kinase C and lipid signaling for sustained cellular responses , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  L. Dubertret,et al.  Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X. , 1994, Molecular pharmacology.

[17]  G. V. Vande Woude,et al.  Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Galimi,et al.  Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. , 1994, The Journal of biological chemistry.

[19]  R. Niles.  Interactions between retinoic acid and protein kinase C in induction of melanoma differentiation. , 1994, Advances in experimental medicine and biology.

[20]  M. Burger,et al.  Murine models of liver metastasis. , 1994, Invasion & metastasis.

[21]  P. Comoglio,et al.  Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. , 1993, British Journal of Cancer.

[22]  P. Parker,et al.  Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. , 1993, The Biochemical journal.

[23]  M. Burger,et al.  Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells. , 1993, Invasion & metastasis.

[24]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[25]  S. Ohno,et al.  Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation. , 1992, The Journal of biological chemistry.

[26]  A. Thody,et al.  Alpha-melanocyte-stimulating hormone stimulates protein kinase C activity in murine B16 melanoma. , 1992, The Journal of endocrinology.

[27]  G. McKnight,et al.  Mutations in the catalytic subunit of cAMP-dependent protein kinase result in unregulated biological activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Hagiwara,et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.

[29]  R. Niles,et al.  Induction of protein kinase C in mouse melanoma cells by retinoic acid. , 1989, Cancer research.

[30]  E. Ormerod,et al.  Increased experimental metastatic capacity of a murine melanoma following induction of differentiation. , 1986, Cancer research.

[31]  G. Poste,et al.  Biochemical regulation of adenylate cyclase in murine melanoma clones with different metastatic properties , 1986, International journal of cancer.

[32]  Pawelek Jm.  Studies on the Cloudman melanoma cell line as a model for the action of MSH. , 1985 .

[33]  J. Pawelek,et al.  Studies on the Cloudman melanoma cell line as a model for the action of MSH. , 1985, The Yale journal of biology and medicine.

[34]  D. Viskochil,et al.  The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells. , 1979, Life sciences.

[35]  M. Burger,et al.  Liver‐colonizing melanoma cells selected from B‐16 melanoma , 1979, International journal of cancer.

[36]  G. Nicolson,et al.  Selection of malignant melanoma variant cell lines for ovary colonization. , 1979, Journal of supramolecular structure.

[37]  G. Nicolson,et al.  Selection and altered properties of brain-colonising metastatic melanoma , 1978, Nature.

[38]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[39]  G. S. Johnson,et al.  N 6 ,O 2 '-dibutyryl adenosine 3',5'-monophosphate induces pigment production in melanoma cells. , 1972, Nature: New biology.